G1 Therapeutics, Inc.
GTHXDelisted Sep 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001560241
G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.
Holders of 5% or more of GTHX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of G1 Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of G1 Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on G1 Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 5, 20243:37 PM ET | Fisher Asset Management, LLC | 13G | 0.00%1.00K shares | NewBelow 5% | May 8, 2023 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell G1 Therapeutics, Inc. shares.
No Form 144 notices for G1 Therapeutics, Inc. are on file.